Related Experiment Video
Updated: Jun 6, 2025

DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
Published on: May 10, 2024
Reliable and precise lipoprotein detection based on a self-priming hairpin-triggered Cas12a/crRNA based signaling
Xiaoya Liu1, Hai Peng2,3, Lisha Gong2,4
1Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Insights
A new method accurately measures intact high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles, crucial for assessing cardiovascular disease risk. This technique offers precise quantification for improved clinical health management.
Area of Science:
- Biochemistry
- Molecular Diagnostics
- Cardiovascular Research
Background:
- Cardiovascular disease is a leading cause of mortality, strongly associated with dyslipidemia.
- Dyslipidemia involves abnormal levels of high-density lipoprotein (HDL) and low-density lipoprotein (LDL).
- Current methods for measuring HDL and LDL often quantify cholesterol content, not intact particle numbers, potentially misrepresenting cardiovascular risk.
Purpose of the Study:
- To develop a novel, precise, and sensitive method for quantifying intact high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles.
- To overcome limitations of conventional methods that measure cholesterol content instead of particle number.
- To provide a tool for accurate assessment of cardiovascular disease risk.
Main Methods:
- Utilized an antibody-based immobilization technique.
- Employed a self-priming hairpin-triggered Cas12a/crRNA signaling strategy.
- Developed a method for direct and sensitive detection of intact HDL and LDL particles without sample isolation.
Main Results:
- Achieved detection limits of 12.3 mg dL-1 for HDL and 5.4 mg dL-1 for LDL.
- Demonstrated accurate and sensitive quantification of intact HDL and LDL particles.
- Validated the method's suitability for analyzing lipoproteins in clinical samples.
Conclusions:
- The developed technique enables precise measurement of actual HDL and LDL particle concentrations.
- This platform offers significant potential for clinical applications in diagnosing and managing dyslipidemia and cardiovascular disease.
- Provides a more accurate assessment of cardiovascular risk by measuring intact lipoprotein particles.
Abstract:
Cardiovascular disease, intimately linked to dyslipidemia, is one of the leading global causes of mortality. Dyslipidaemia often presents as an elevated concentration of low-density lipoprotein (LDL) and a decreased concentration of high-density lipoprotein (HDL). Therefore, accurately measuring the levels of LDL and HDL particles is crucial for assessing the risk of developing cardiovascular diseases. However, conventional approaches can commonly quantify HDL/LDL particles by detecting cholesterol or protein molecules within them, which may fail to reflect the number of intact particles. In addition, these approaches are sometimes tedious and time-consuming, highlighting the need for a novel method for precise and effective identification of intact HDL and LDL particles. We have devised a technique that allows accurately and sensitively determining the levels of intact HDL and LDL in a sample without the need for isolation. This method relies on antibody-based immobilization and a self-priming hairpin-triggered Cas12a/crRNA signaling strategy. Based on the elegant design, this technique can be employed to directly and precisely measure the concentration of "actual" HDL and LDL particles, rather than the cholesterol content inside HDL and LDL. The approach has detection limits of 12.3 mg dL-1 and 5.4 mg dL-1 for HDL and LDL, respectively, and is also suitable for analyzing lipoproteins in clinical samples. Hence, this platform exhibits immense potential for clinical applications and health management.
More Related Videos
10:16Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
Published on: August 16, 2024
09:03Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022